Traditional Chinese medicine composition for improving kidney injury by adjusting number and percentage of neutrophils in peripheral blood as well as preparation method and application of traditional Chinese medicine composition

Through the use of traditional Chinese medicine preparations prepared by using Chinese medicine compositions such as yam, the kidney sub-health status related to abnormal neutrophils is solved, and the renal function is significantly improved and restored, providing a safe and effective treatment plan.

CN118987138APending Publication Date: 2024-11-22ZHUJI SHANGZHAN MEDICAL RESEARCH CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411063266.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-05
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Abnormal neutrophil count or ratio may indicate a sub-healthy state of the kidney, but prior art is difficult to effectively treat and improve renal function, especially if renal tissue does not reach a clear disease state.

Method used

Provide a traditional Chinese medicine composition, including yam, Cistanche, Yizhiren, cypress kernel, Suoyang, Cuscuta, raspberry, jujube kernel, Jinyingzi, whole Trichosanthes kirilowii and Salvia miltiorrhiza, and Chinese herbal preparations are prepared by decoction and solid liquid separation. , used to restore kidney tissue and improve renal function.

Benefits of technology

After taking it for 30 to 60 days, the neutrophil ratio can tend to 60%. After 3 to 6 months, the renal function will be significantly improved. The drugs are not damaged by the human body, are easy to obtain and safe, and can simultaneously improve the internal organs' running ability and improve the ability to improve the Patient immunity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118987138A_ABST
    Figure CN118987138A_ABST
Patent Text Reader

Abstract

The invention provides a traditional Chinese medicine composition for improving kidney injury by adjusting the number and percentage of neutrophils in peripheral blood as well as a preparation method and application of the traditional Chinese medicine composition, and belongs to the technical field of traditional Chinese medicine preparations. The invention provides a medicine formula for recovering kidney tissues and improving kidney functions. The medicine formula comprises the following components in parts by mass: 15-25 parts of Chinese yam, 10-20 parts of cistanche, 10-20 parts of fructus alpiniae oxyphyllae, 10-20 parts of semen boitae, 10-20 parts of cynomorium songaricum, 8-15 parts of semen cuscutae, 8-15 parts of raspberry, 8-15 parts of spina date seed, 8-15 parts of fructus rosae laevigatae, 8-15 parts of fructus trichosanthis and 8-15 parts of radix salviae miltiorrhizae. According to the medicine formula provided by the invention, a patient takes the medicine for 30-60 days, blood routine examination shows that the ratio of neutrophil can tend to 60%, and the renal function can be obviously improved after 3-6 months.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of Chinese medicine preparations, and in particular to a Chinese medicine composition for regulating the number and percentage of peripheral blood neutrophils to improve kidney damage, and a preparation method and application thereof. Background Art

[0002] The application of peripheral blood leukocyte count and ratio changes in disease prevention and treatment is expanding and deepening. Leukocytes are divided into granulocytes, lymphocytes and monocytes. According to the different particles contained in the cytoplasm of granulocytes, they can be divided into neutrophils, eosinophils and basophils.

[0003] There are many reasons for changes in the number and ratio of white blood cells. Both endogenous and exogenous diseases can cause changes in the number and ratio of certain white blood cells. When the number and ratio of white blood cells return to normal, the corresponding diseases and conditions are changed.

[0004] The reference values ​​of peripheral blood indicators used by various medical systems are slightly different. The reference range of neutrophil count is generally 2.00-7.00, and the reference range of ratio is generally 50-70%. We believe that the average value (middle value) of the reference range is the ideal balance state (10% of the middle value of the reference range is the fluctuation range of the ideal balance state). When any value of the count and ratio exceeds the upper and lower limits of the reference range, it is unbalanced.

[0005] When the number and ratio of white blood cells are abnormal but have not yet reached a disease state, the relationship between white blood cells and health is worth exploring. Through the summary and analysis of a large number of cases, the working capacity of the internal organs is related to the number and ratio of white blood cells. Among them, neutrophils are related to the working capacity of the kidneys. Only when the number and ratio of neutrophils are abnormal, it is necessary to consider whether the kidneys are in a sub-healthy state.

[0006] Based on the basic theory of traditional Chinese medicine, the kidney is the "innate foundation" of the human body. The kidney has the functions of controlling growth and development, reproduction, controlling water, controlling qi, producing marrow to fill the brain and transform blood, and nourishing and warming various internal organs, and participates in the whole process of human growth and development. In our research, many physical discomforts are related to the working ability of the kidney. At this time, it is not necessarily that the kidney tissue is in a diseased state or a clear pathological conclusion has appeared. The malnutrition of the kidney can lead to insufficient development or atrophy of the kidney tissue, resulting in insufficient kidney-related working ability, and then causing many physical discomforts. At this time, the number or ratio of neutrophils may appear abnormal. How to treat kidney diseases related to abnormal number or ratio of neutrophils is a technical problem to be solved by the present invention. Summary of the invention

[0007] The purpose of the present invention is to provide a drug formulation for restoring kidney tissue and improving kidney function. After taking the drug for 30 to 60 days, blood routine examination shows that the neutrophil ratio can approach 60%, and kidney function is significantly improved after 3 to 6 months.

[0008] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0009] The invention provides a medicine formula for restoring kidney tissue and improving kidney function, comprising the following components in parts by weight: 15-25 parts of yam, 10-20 parts of cistanche deserticola, 10-20 parts of alpinia oxyphylla, 10-20 parts of arborvitae seeds, 10-20 parts of cynomorium songaricum, 8-15 parts of dodder seeds, 8-15 parts of raspberry, 8-15 parts of spiny jujube seeds, 8-15 parts of rosa laevigata fruits, 8-15 parts of whole trichosanthes, and 8-15 parts of salvia miltiorrhiza.

[0010] The present invention also provides a method for preparing the pharmaceutical formulation, comprising the following steps:

[0011] (1) mixing the Chinese yam, Cistanche deserticola, Alpinia oxyphylla, Platycladus orientalis seed, Cynomorium songaricum, Cuscuta australis, Rubus idaeus, Semen Ziziphi spinulosus, Rosa laevigata, Trichosanthes kirilowii and Salvia miltiorrhiza, boiling with water, and separating the solid from the liquid to obtain a filter residue and a first filtrate;

[0012] (2) adding water to the filter residue of step (1) and continuing to boil to separate the solid and liquid to obtain a second filtrate;

[0013] (3) Mixing the first filtrate and the second filtrate to obtain a Chinese medicine preparation.

[0014] Preferably, the amount of water added in step (1) is 3 to 5 times the mass of the mixed traditional Chinese medicine, the water is first added and the mixture is soaked for 20 to 50 minutes, and the decocting time is 20 to 50 minutes.

[0015] Preferably, the amount of water added in step (2) is 2 to 3 times the mass of the filter residue, and the decocting time is 20 to 40 minutes.

[0016] The present invention also provides an application of the drug formulation or the traditional Chinese medicine preparation obtained by the preparation method in preparing drugs for kidney tissue changes and renal insufficiency associated with abnormal neutrophil number and ratio.

[0017] The drug formulation provided by the present invention does not cause any harm to the human body and can simultaneously improve the functioning capacity of internal organs; the materials are safe, easily available, have little toxic and side effects, and can also enhance the patient's immunity; after taking the drug for 30 to 60 days, the neutrophil ratio of patients with renal impairment can approach 60% through routine blood tests, and after taking the drug for 3 to 6 months, the renal function is significantly improved, and an accurate quantitative method is also provided for the healthy recovery of renal function. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 This is the blood routine test result of Peng* in Experimental Example 1;

[0019] Figure 2 This is the test result of biochemical indexes of Peng* in Experimental Example 1;

[0020] Figure 3 This is the result of kidney ultrasound examination of Peng* in Experimental Example 1;

[0021] Figure 4 This is the blood routine test result of Peng* in Experimental Example 1;

[0022] Figure 5 This is the test result of biochemical indexes of Peng* in Experimental Example 1;

[0023] Figure 6 This is the result of kidney ultrasound examination of Peng* in Experimental Example 1;

[0024] Figure 7 This is the blood routine test result of Peng*Ming in Experimental Example 2;

[0025] Figure 8 This is the test result of biochemical indexes of Peng*Ming in Experimental Example 2;

[0026] Fig. 9 This is the result of kidney ultrasound examination of Peng Ming in Experimental Example 2;

[0027] Fig.10 This is the blood routine test result of Peng*Ming in Experimental Example 2;

[0028] Fig.11 This is the test result of biochemical indexes of Peng*Ming in Experimental Example 2;

[0029] Fig.12 This is the result of kidney ultrasound examination of Peng Ming in Experimental Example 2;

[0030] Fig.13 This is the result of kidney ultrasound examination of Wang Lin in Experimental Example 3;

[0031] Fig.14 This is the blood routine test result of Wang*Lin in Experimental Example 3;

[0032] Fig.15 This is the blood routine test result of Wang*Lin in Experimental Example 3;

[0033] Fig.16 This is the blood routine test result of Wang*Lin in Experimental Example 3;

[0034] Fig.17 This is the blood routine test result of Wang*Lin in Experimental Example 3;

[0035] Fig.18 This is the B-ultrasound test result of Wang*Lin’s kidney in Experimental Example 3. DETAILED DESCRIPTION

[0036] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.

[0037] Example 1

[0038] A drug formulation for restoring kidney tissue and improving kidney function, comprising the following components in parts by mass: 15 parts of yam, 20 parts of cistanche deserticola, 20 parts of alpinia oxyphylla, 10 parts of cynomorium songaricum, 20 parts of dodder seeds, 8 parts of rubus idaeus, 15 parts of spiny jujube seeds, 15 parts of rosa laevigata fruits, 15 parts of trichosanthes kirilowii, and 15 parts of salvia miltiorrhiza.

[0039] The above-mentioned drug formulation is prepared by the following steps:

[0040] (1) Mix yam, Cistanche deserticola, Alpinia oxyphylla, Platycladus orientalis, Cynomorium songaricum, Cuscuta australis, Rubus idaeus, Ziziphus jujuba seeds, Rosa laevigata, Trichosanthes kirilowii and Salvia miltiorrhiza, soak in water for 50 minutes, wherein the amount of water added is 3 times the weight of the mixed Chinese medicine, and then decoct for 50 minutes, and separate the solid and liquid to obtain a filter residue and a first filtrate;

[0041] (2) adding water to the filter residue of step (1) in an amount of twice the weight of the filter residue, and continuing to boil for 40 minutes to separate the solid and liquid to obtain a second filtrate;

[0042] (3) Mixing the first filtrate and the second filtrate to obtain a Chinese medicine preparation.

[0043] Example 2

[0044] A drug formulation for restoring kidney tissue and improving kidney function, comprising the following components in parts by mass: 25 parts of yam, 10 parts of cistanche deserticola, 10 parts of alpinia oxyphylla, 10 parts of cynomorium songaricum, 15 parts of dodder seeds, 15 parts of rubus idaeus, 8 parts of spiny jujube seeds, 8 parts of rosa laevigata fruits, 8 parts of trichosanthes kirilowii, and 8 parts of salvia miltiorrhiza.

[0045] The above-mentioned drug formulation is prepared by the following steps:

[0046] (1) Mix yam, Cistanche deserticola, Alpinia oxyphylla, Platycladus orientalis, Cynomorium songaricum, Cuscuta australis, Rubus idaeus, Ziziphus jujuba seeds, Rosa laevigata, Trichosanthes kirilowii and Salvia miltiorrhiza, soak in water for 20 minutes, wherein the amount of water added is 5 times the weight of the mixed Chinese medicine, and then decoct for 30 minutes, and separate the solid and liquid to obtain a filter residue and a first filtrate;

[0047] (2) adding water to the filter residue of step (1), the amount of water added being 3 times the mass of the filter residue, and continuing to boil for 30 minutes, separating the solid and the liquid, and obtaining a second filtrate;

[0048] (3) Mixing the first filtrate and the second filtrate to obtain a Chinese medicine preparation.

[0049] Example 3

[0050] A drug formulation for restoring kidney tissue and improving kidney function, comprising the following components in parts by mass: 20 parts of yam, 15 parts of cistanche deserticola, 15 parts of alpinia oxyphylla, 15 parts of cynomorium songaricum, 10 parts of dodder seeds, 10 parts of raspberry, 10 parts of spiny jujube seeds, 10 parts of rosa laevigata fruits, 10 parts of whole trichosanthes, and 10 parts of salvia miltiorrhiza.

[0051] The above-mentioned drug formulation is prepared by the following steps:

[0052] (1) Mix yam, Cistanche deserticola, Alpinia oxyphylla, Platycladus orientalis, Cynomorium songaricum, Cuscuta australis, Rubus idaeus, Ziziphus jujuba seeds, Rosa laevigata, Trichosanthes kirilowii and Salvia miltiorrhiza, soak in water for 30 minutes, wherein the amount of water added is 4 times the weight of the mixed Chinese medicine, and then decoct for 30 minutes, and separate the solid and liquid to obtain a filter residue and a first filtrate;

[0053] (2) adding water to the filter residue of step (1) in an amount of twice the weight of the filter residue, and continuing to boil for 30 minutes to separate the solid and liquid to obtain a second filtrate;

[0054] (3) Mixing the first filtrate and the second filtrate to obtain a Chinese medicine preparation.

[0055] Experimental Example 1

[0056] Peng*, male, a retired soldier, reported that he had experienced hematuria during military training and now often feels back pain. At the end of September 2023, Example 1 of the present invention was started for maintenance. Before the start, a routine blood test was performed on September 26, 2023. Figure 1 It showed that the white blood cell count was 5.28, the neutrophil count was 2.66, and the percentage was 50.3%, both tending to the lower limit of the reference range; Figure 2 The biochemical renal function showed that urea was 7.41, close to the upper limit of the reference range of 8, creatinine was 97.5, exceeding the upper limit of the reference range of 97, uric acid was 398.3, close to the upper limit of the reference range of 416.5, estimated glomerular filtration rate (Cr) was 78.8, tending to the lower limit of the reference range of 60, and estimated glomerular filtration rate (Cr+CysC) was 71.7, tending to the lower limit of the reference range of 60. Figure 3 Kidney B-ultrasound showed that the right kidney cyst was 0.5*0.5cm, the left kidney cyst was 0.7*0.4cm, and the kidney stone in the cyst was 0.4cm. The working capacity of the kidney was reduced and there were pathological conditions. After starting the drug formulation of the present invention, it was taken for 6 months. On March 25, 2024, the blood routine was rechecked. Figure 4 It was found that the white blood cell count was 5.64, the neutrophil count was 3.32, and the percentage was 58.8%, which was an improvement compared with six months ago; Figure 5 The biochemical renal function showed that urea was 7.32, creatinine was 83.6, and uric acid was 346. The renal function was improved compared with six months ago. The estimated glomerular filtration rate (Cr) was 94.3, and the estimated glomerular filtration rate (Cr+CysC) was 84.5, which was a significant improvement. Figure 6 The B-ultrasound of the kidneys showed that there were no cysts or concretions in both kidneys, the intrarenal structure was clear, there was no fluid separation in the collecting system, the ureters were not dilated, and the blood flow signals of both kidneys were normal.

[0057] Experimental Example 2

[0058] Peng Ming, male, veteran, had poor sleep for many years, and had underlying diseases including gastric erosion and intestinal metaplasia, severe coronary artery blockage, etc. In September 2023, the maintenance of Example 1 of the present invention was started. On August 30, 2023, the blood routine showed ( Figure 7 ), white blood cell count 7.23, neutrophil count 3.30, slightly low, neutrophil percentage 45.6%, below the lower limit of the reference range of 50%, red blood cells and hemoglobin are ideal, platelets 108, below the lower limit of the reference range of 125. Figure 8 The biochemical renal function showed that urea was 4.57, which was close to the lower limit of the reference range of 3.6, and creatinine was 101.6, which was close to the upper limit of the reference range of 115. Fig. 9 The kidney ultrasound on September 14, 2023 showed that the right kidney was 10.2*5.7*6.4cm, the left kidney was 10.0*4.6*5.5cm, the right kidney stone was 0.4*0.4cm, the left kidney stone was 0.3*0.3cm, and there were multiple cysts in the left kidney, the largest of which was 2.1*1.8cm. After taking this prescription for 8 months, relevant examinations were performed on May 20, 2024. Fig.10 The blood test showed that the white blood cell count was 6.96, the neutrophil count was 2.99, the percentage was 43%, and the platelets were 120, with little change in the data; Fig.11 The biochemical renal function showed that urea was 5.98 and creatinine was 92.10, which was an improvement; Fig.12 The size of the right kidney was 10.9*5.3*8.1cm, and that of the left kidney was 10.2*5.0*6.7cm. The kidney tissue was significantly enlarged, indicating that the drug formulation of the present invention was effective in nourishing kidney yin and improving renal function. However, stones and cysts were not effectively improved, possibly because the elderly had weak liver and digestive systems, insufficient nutrient absorption and waste metabolism capabilities, and a short period of medication.

[0059] Experimental Example 3

[0060] Wang Lin, male, undergoes dialysis three times a week due to uremia and blood transfusion once a month. On May 29, 2023, he was examined in a hospital in Guangzhou and considered a kidney transplant. Fig.13 The kidney size is shown as 79mm*37*45mm for the left kidney and 75*33*41mm for the right kidney. Before kidney transplantation, consider using the third embodiment of the present invention to improve body function. Fig.14 The blood test on August 9, 2023 showed: white blood cell count 2.82, neutrophil count 1.85, red blood cell count (monthly blood transfusion) 3.77, hemoglobin 114, platelet 120, all below the lower limit of the reference range. The drug formulation of the present invention was immediately started for maintenance. After taking it for 6 months, the patient felt that his spirit and spirit had improved. On October 2, 23, a blood test was performed. Fig.15 The results showed that the white blood cell count was 3.01, the neutrophil count was 2.00, and although the red blood cell count was lower than in August, the rate of decline was slower than before, so there was no need for blood transfusion. The blood transfusion was stopped, and dialysis was continued three times a week in conjunction with the patented prescription. Fig.16 The blood test on December 6, 2023 showed a white blood cell count of 3.81 and a neutrophil count of 2.66, with data steadily improving. I caught a cold before the Spring Festival, and my body was slightly fluctuating. I felt that I recovered faster than before. After six months of adherence to this patented prescription, although dialysis is still 3 times a week, my mental state and blood have recovered well. On March 25, 2024, I rechecked my blood test. Fig.17 The results showed that the white blood cell count was 3.39, the neutrophil count was 2.4, the red blood cell count without blood transfusion was 3.51, the hemoglobin was 111, and the platelet count was 186. Compared with the data six months ago, the overall data has improved; kidney B-ultrasound ( Fig.18 ) showed that the left kidney was 84*46mm and the right kidney was 84*46mm. The kidney tissue was obviously larger and fuller than six months ago.

[0061] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A pharmaceutical formulation for restoring kidney tissue and improving renal function, characterized in that: The invention comprises the following components in parts by weight: 15-25 parts of yam, 10-20 parts of cistanche deserticola, 10-20 parts of alpinia oxyphylla, 10-20 parts of arborvitae seeds, 10-20 parts of cynomorium songaricum, 8-15 parts of dodder seeds, 8-15 parts of raspberry, 8-15 parts of spiny jujube seeds, 8-15 parts of rosa laevigata fruits, 8-15 parts of whole trichosanthes, and 8-15 parts of salvia miltiorrhiza.

2. A method for preparing the pharmaceutical formulation according to claim 1, characterized in that: The steps include: (1) mixing the Chinese yam, Cistanche deserticola, Alpinia oxyphylla, Platycladus orientalis seed, Cynomorium songaricum, Cuscuta australis, Rubus idaeus, Semen Ziziphi spinulosus, Rosa laevigata, Trichosanthes kirilowii and Salvia miltiorrhiza, boiling with water, and separating the solid from the liquid to obtain a filter residue and a first filtrate; (2) adding water to the filter residue of step (1) and continuing to boil to separate the solid and liquid to obtain a second filtrate; (3) Mixing the first filtrate and the second filtrate to obtain a Chinese medicine preparation.

3. The preparation method according to claim 2, characterized in that: The amount of water added in step (1) is 3 to 5 times the mass of the mixed traditional Chinese medicine. After adding water, the mixture is first soaked for 20 to 50 minutes, and the decocting time is 20 to 50 minutes.

4. The preparation method according to claim 3, characterized in that: The amount of water added in step (2) is 2 to 3 times the mass of the filter residue, and the decocting time is 20 to 40 minutes.

5. Use of a Chinese medicine preparation obtained by the pharmaceutical formulation according to claim 1 or the preparation method according to any one of claims 2 to 4 in the preparation of a medicine for kidney tissue changes and renal insufficiency associated with abnormal neutrophil number and ratio.

Citation Information

Patent Citations

  • Preparation method of healthcare wine

    CN103173323A